JPRN-UMIN000011725已完成未知
Prospective, randomized, open-label,clinical trial comparing the effects of amlodipine alone and irbesartan/amlodipine combination on blood pressure, endothelial function and makers for obesity/oxidative stress/chronic kidney diseases - Prospective, randomized, open-label,clinical trial comparing the effects of amlodipine alone and irbesartan/amlodipine combination
ational Defense Medical College0 个研究点目标入组 30 人开始时间: 2013年9月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Allergy against 2) Either level of aspartate aminotransaminase or alanine aminotransferase exceeds three-fold of the normal limits. 3) End stage renal disease 4) Subjects whose doctor in charge do not agree to join the trial
研究者
相似试验
已完成
4 期
Prospective, randomized, open-label,clinical trial comparing the effects of olmesartan/azelnidipine and candesartan/amlodipine on blood pressure, endothelial function and makers for obesity/oxidative stress/chronic kidney diseasesHypertensionJPRN-UMIN000005684ational Defense Medical College30
已完成
4 期
Prospective, randomized, open-label,clinical trial comparing the effects of telmisartan and valsartan on blood pressure, endothelial function and makers for obesity/oxidative stress/chronic kidney diseasesHypertensionJPRN-UMIN000005685ational Defense Medical College30
已完成
不适用
Prospective, randomized, open-label,clinical trial comparing the effects of hydrogen tablet and placebo on blood and urine makers for cardiovascular diseasescardiovascular disease, diabetes and dyslipidemiaJPRN-UMIN000032701Tokorozawa Heart Center30
已完成
不适用
Prospective, randomized, open-label,clinical trial comparing the effects of febuxostat and allopurinol on blood urate levels, endothelial function and makers for obesity/oxidative stress/chronic kidney diseasesHyperuricemiaJPRN-UMIN000011741ational Defense Medical College31
已完成
不适用
Prospective, randomized, open-label,clinical trial comparing the effects of olmesartan and imidapril on blood pressure, endothelial function and makers for obesity/oxidative stress/chronic kidney diseasesHypertensionJPRN-UMIN000032702ational Defense Medical College30